Literature DB >> 3487417

The cardiovascular manifestations of systemic sclerosis (scleroderma).

W P Follansbee.   

Abstract

In conclusion, systemic sclerosis is both a fascinating and frustrating affliction. It is a systemic disease of multiple stages. Prognosis is dependent on the site and extent of visceral involvement. There is evidence to implicate the vascular system as the primary target organ of the disease. The cardiovascular manifestations include myocardial fibrosis, pericarditis, and a variety of arrhythmias and conduction abnormalities. Intractable heart failure or sudden cardiac death can ensue. Cardiac involvement in systemic sclerosis portends an ominous prognosis, and is probably most directly related to the extent of myocardial fibrosis which is present. The pathogenesis of myocardial fibrosis has not been determined, but it appears to be a result of an impairment of myocardial perfusion at both the small artery and microvasculature level. Obstructive, vasospastic, and devascularization factors all may be playing a role.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487417     DOI: 10.1016/0146-2806(86)90022-8

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  6 in total

Review 1.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 2.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

3.  Serum levels of tissue inhibitors of metalloproteinase 2 in patients with systemic sclerosis with duration more than 2 years: correlation with cardiac and pulmonary abnormalities.

Authors:  Amira Shahin; Amani Elsawaf; Shahira Ramadan; Olfat Shaker; Mona Amin; Mohamed Taha
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 4.  The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.

Authors:  Alessandro Durante; Sofia Bronzato
Journal:  J Clin Med Res       Date:  2015-04-08

5.  Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests.

Authors:  Alessandra Vacca; Roberta Montisci; Pietro Garau; Paolo Siotto; Matteo Piga; Alberto Cauli; Massimo Ruscazio; Luigi Meloni; Sabino Iliceto; Alessandro Mathieu
Journal:  Arthritis Res Ther       Date:  2013-01-09       Impact factor: 5.156

6.  Case 3: - congestive heart failure in male with systemic sclerosis.

Authors:  Caio Bosquiero Zanetti; Mariana Bittar Lopes; André Marun Lyrio; Pompeu Ribeiro de Campos; Rubens Bonfiglioli; Maria Aparecida Barone Teixeira
Journal:  Arq Bras Cardiol       Date:  2013-07       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.